Stocks · Health care · Pharmaceutical Preparations

PALVELLA THERAPEUTICS, INC.

PVLA Clue Score43
United States Fiscal year ends December CIK 0001583648 Results filed 5 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Kathleen Goin
21 Oct 2026
Chief Operating Officer
Sold after exercise
607
$126.19
$76.60K
Kathleen Goin
21 Oct 2026
Chief Operating Officer
Sold after exercise
1,663
$125.16
$208.15K
Kathleen Goin
21 Oct 2026
Chief Operating Officer
Sold after exercise
2,043
$123.62
$252.56K

What was left out

Form 4 filings counted 2
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 17
Sales straight out of an exercise 3
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 4,313
History held since 8 Jul 2015